Can a common drug stop infections before they start?
NCT ID NCT07054320
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests whether the drug rapamycin (sirolimus) can help prevent infections or make them less severe. Fifteen adults will take the drug for 6 months while researchers monitor their health through blood tests, heart checks, and surveys. The goal is to see if rapamycin is safe and effective for reducing infection-related illness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIOUS DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hoskinson Health and Wellness Clinic
Gillette, Wyoming, 82718, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Putting dietitians in charge of hospital nutrition: a recipe for shorter stays?
- 23,000 seniors join study to unlock secrets of aging and infection
- Cash for breastfeeding: a new way to boost baby health?
- New shingles vaccine shows promise in Head-to-Head trial
- Awe-Inspiring nature game may boost vaccination and Mask-Wearing
- New digital tool aims to curb antibiotic overuse in belgian Doctor's offices